Arunjyothi Bio Ventures Limited (BOM:530881)
India · Delayed Price · Currency is INR 5.30
-0.11 (-2.03%)
At close: Jul 24, 2026
Arunjyothi Bio Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 272.42 | 277.54 | 278.84 | 204.32 | 17.35 | 29.71 |
| 272.42 | 277.54 | 278.84 | 204.32 | 17.35 | 29.71 | |
Revenue Growth (YoY) | 2.81% | -0.46% | 36.48% | 1077.40% | -41.59% | -46.11% |
Cost of Revenue | - | 6.68 | 56.79 | 118.61 | 14.96 | 28.75 |
Gross Profit | 272.42 | 270.87 | 222.05 | 85.71 | 2.4 | 0.96 |
Selling, General & Admin | 116.18 | 113.78 | 90.58 | 46.64 | 0.08 | 0.66 |
Other Operating Expenses | 125.43 | 127.05 | 81.35 | 11.23 | 0.66 | -0.47 |
Operating Expenses | 292.55 | 274.42 | 202.38 | 78.01 | 0.74 | 0.19 |
Operating Income | -20.13 | -3.55 | 19.67 | 7.7 | 1.65 | 0.77 |
Interest Expense | -18.68 | -20.06 | -25.73 | -21.05 | -0.02 | -0 |
Interest & Investment Income | - | 1.18 | 2.81 | 0.37 | - | - |
Other Non Operating Income (Expenses) | 1.27 | -0.42 | -0.16 | -0 | -0.05 | -0.01 |
EBT Excluding Unusual Items | -37.54 | -22.84 | -3.41 | -12.99 | 1.58 | 0.76 |
Gain (Loss) on Sale of Assets | - | -1.19 | - | - | - | - |
Other Unusual Items | -27.37 | -27.37 | - | - | - | - |
Pretax Income | -64.91 | -51.4 | -3.41 | -12.99 | 1.58 | 0.76 |
Income Tax Expense | -5.22 | -6.04 | -0.65 | -9.5 | 0.41 | 0.2 |
Net Income | -59.69 | -45.36 | -2.76 | -3.49 | 1.17 | 0.56 |
Net Income to Common | -59.69 | -45.36 | -2.76 | -3.49 | 1.17 | 0.56 |
Net Income Growth | - | - | - | - | 107.62% | -17.59% |
Shares Outstanding (Basic) | 194 | 186 | 178 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 194 | 186 | 178 | 21 | 21 | 21 |
Shares Change (YoY) | 2.33% | 4.94% | 757.63% | -0.01% | 0.01% | - |
EPS (Basic) | -0.31 | -0.24 | -0.02 | -0.17 | 0.06 | 0.03 |
EPS (Diluted) | -0.31 | -0.24 | -0.02 | -0.17 | 0.06 | 0.03 |
EPS Growth | - | - | - | - | 107.41% | -18.09% |
Free Cash Flow | - | 74.54 | -44.22 | -163.08 | -322.54 | -7.82 |
Free Cash Flow Per Share | - | 0.40 | -0.25 | -7.88 | -15.57 | -0.38 |
Gross Margin | 100.00% | 97.59% | 79.63% | 41.95% | 13.80% | 3.24% |
Operating Margin | -7.39% | -1.28% | 7.05% | 3.77% | 9.53% | 2.60% |
Profit Margin | -21.91% | -16.34% | -0.99% | -1.71% | 6.73% | 1.89% |
Free Cash Flow Margin | - | 26.86% | -15.86% | -79.81% | -1858.69% | -26.31% |
EBITDA | 14.44 | 29.01 | 49.1 | 27.83 | - | - |
EBITDA Margin | 5.30% | 10.45% | 17.61% | 13.62% | - | - |
D&A For EBITDA | 34.57 | 32.56 | 29.43 | 20.13 | - | - |
EBIT | -20.13 | -3.55 | 19.67 | 7.7 | 1.65 | 0.77 |
EBIT Margin | -7.39% | -1.28% | 7.05% | 3.77% | 9.53% | 2.60% |
Effective Tax Rate | - | - | - | - | 25.98% | 26.00% |
Revenue as Reported | 273.69 | 278.72 | 281.65 | 204.68 | 17.35 | 32.51 |
Advertising Expenses | - | 0.05 | 0.06 | 0.14 | - | 0.02 |